Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd.,...
Read moreMateon Therapeutics, Inc dedicated to development OT-101, a TGF-β antisense drug candidate, announced that Mateon has delivered the requisite testing...
Read moreAgilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and...
Read moreIktos, a French artificial intelligence (AI) start-up company, has joined forces with California-based research institute SRI International to accelerate discovery...
Read moreApplied BioMath , the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and...
Read moreAvacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a...
Read moreAmgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate...
Read moreMerck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with...
Read moreBoth organisations have collaborated successfully on the event since 2016, when Rapid took on the annual event. The future cooperation...
Read moreOakrum Pharma, LLC ("Oakrum"), in collaboration with SunGen Pharma, LLC ("SunGen"), announced the U.S. launch and commercial shipment of a...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.